Circulating tumor DNA methylation marker-based minimal residual diseases detection and recurrence monitoring of cancer

被引:0
|
作者
Wang, Huiyong
Pan, Xiaobao
Wang, Lin
Li, Chao
Ma, Chao
Yu, Shuai
Meng, Fanyang
Liu, Jing
Liu, Liang
Cao, Zhanbo
机构
[1] Smartquerier Gene Technol Shanghai Co Ltd, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Pancreat Surg, Shanghai, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15172
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Circulating tumor DNA analysis to detect minimal residual disease and predict recurrence in patients with resectable pancreatic cancer.
    Yang, Liu
    Jiang, Jiahong
    Ye, Song
    Xu, Yaping
    Huang, Dongsheng
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer
    Tie, Jeanne
    Wang, Yuxuan
    Tomasetti, Cristian
    Li, Lu
    Springer, Simeon
    Kinde, Isaac
    Silliman, Natalie
    Tacey, Mark
    Wong, Hui-Li
    Christie, Michael
    Kosmider, Suzanne
    Skinner, Iain
    Wong, Rachel
    Steel, Malcolm
    Tran, Ben
    Desai, Jayesh
    Jones, Ian
    Haydon, Andrew
    Hayes, Theresa
    Price, Tim J.
    Strausberg, Robert L.
    Diaz, Luis A., Jr.
    Papadopoulos, Nickolas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Gibbs, Peter
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (346)
  • [33] Circulating tumour DNA- based minimal residual disease detection for biliary tract cancer
    Li, Z.
    Yan, P.
    Hao, Q.
    Guo, L.
    Pang, F.
    Jiang, X.
    Yu, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S225 - S226
  • [34] DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients
    Sharma, Gayatri
    Mirza, Sameer
    Parshad, Rajinder
    Gupta, Siddartha Datta
    Ralhan, Ranju
    TUMOR BIOLOGY, 2012, 33 (06) : 1837 - 1843
  • [35] Circulating cell-free DNA in serum as a marker for the early detection of tumor recurrence in breast cancer patients
    Bera, A.
    Eidelman, O.
    Russ, E.
    Landa, A.
    Karaian, J.
    Eklund, M.
    Hu, H.
    Pollard, H. B.
    Shriver, C. D.
    Srivastava, M.
    CANCER RESEARCH, 2019, 79 (04)
  • [36] Circulating tumor DNA in Egyptian women with breast Cancer: A marker for detection of primary cases and early prediction of recurrence
    Gameel, Abdallah M.
    Talaat, Randa M.
    Sakr, Moustafa A.
    Selim, Mohamed A.
    Alil, Doaa F. A. Abo
    Elkhouly, Enas A.
    CLINICA CHIMICA ACTA, 2024, 562
  • [37] ASSESSMENT OF CIRCULATING TUMOR DNA STATUS AS A PROGNOSTIC MARKER FOR RECURRENCE DETECTION IN PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER
    Cumarasamy, Shivaram
    Laliotis, George
    White, Elshaddai
    Rich, Jordan
    Dutta, Punashi
    Sharma, Shruti
    Calhoun, Mark
    Elnaggar, Adam
    Liu, Minetta
    Attalla, Kyrollis
    Mehrazin, Reza
    Wiklund, Peter
    Sfakianos, John
    JOURNAL OF UROLOGY, 2023, 209 : E981 - E982
  • [38] Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
    Ran Zhong
    Rui Gao
    Wenhai Fu
    Caichen Li
    Zhenyu Huo
    Yuewen Gao
    Yi Lu
    Feng Li
    Fan Ge
    Hengjia Tu
    Zhixuan You
    Jianxing He
    Wenhua Liang
    BMC Medicine, 21
  • [39] Accuracy of minimal residual disease detection by circulating tumor DNA profiling in lung cancer: a meta-analysis
    Zhong, Ran
    Gao, Rui
    Fu, Wenhai
    Li, Caichen
    Huo, Zhenyu
    Gao, Yuewen
    Lu, Yi
    Li, Feng
    Ge, Fan
    Tu, Hengjia
    You, Zhixuan
    He, Jianxing
    Liang, Wenhua
    BMC MEDICINE, 2023, 21 (01)
  • [40] Circulating tumor DNA-based molecular residual disease detection and recurrence monitoring in patients with advanced or metastatic anal squamous cell carcinoma
    Azzi, Georges
    Tavallai, Mehrad
    Botta, Gregory P.
    Tejani, Mohamedtaki Abdulaziz
    Hanna, Diana L.
    Jurdi, Adham Adel
    Budde, Griffin
    Krinshpun, Shifra
    Maninder, Minu
    Aushev, Vasily N.
    Olshan, Perry
    Billings, Paul R.
    Aleshin, Alexey
    Kasi, Pashtoon Murtaza
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)